Liao’s team also developed the first vaccine against endothelin-1 receptor type A (ETAR) (ETRQβ-002 vaccine) to treat the pulmonary arterial hypertension (PAH) (Dai et al., 2019). This evidence concerns the gene EDNRA and pulmonary arterial hypertension.